Anzeige
Mehr »
Login
Freitag, 17.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Paukenschlag in den USA - diese Aktien könnten profitieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
479 Leser
Artikel bewerten:
(2)

Arizton Advisory & Intelligence: The Demand for Natural Fertility Supplements is Boosting the Global Fertility Supplement Market. The Demand for Fertility Supplements to Reach Almost USD 3 Billion, A 2X Growth, By 2027 - Arizton

CHICAGO, Jan. 10, 2023 /PRNewswire/ -- According to Arizton's latest research report, the fertility supplements market is likely to grow at a CAGR of 8% during 2021-2027. Factors such as growing awareness regarding fertility health, increasing advanced maternal age population (women) in developed and emerging markets, rapidly increasing infertile couples worldwide, and awareness of infertility issues among the global adult population are boosting the fertility supplements market.

Fertility_Supplements_Market

Several global and regional players in the market offer a wide range of fertility supplements in natural, synthetic, and blend ingredients. Consumer preference and better clinical outcomes are increasing the demand for fertility supplements. Most vendors are increasingly focused on marketing and extending their product portfolio to gain a competitive edge over other market players. Rapid advances in the fertility supplement industry have significantly impacted the growth of products.

Europe is a highly dominating global fertility supplements market region, valued at USD 610.79 million in 2021. Due to the higher awareness level about fertility care and supplements, high expenditure and acceptance of fertility-boosting solutions are expected to fuel the region's market growth. In addition, the increasing infertility prevalence, changing lifestyle, delayed pregnancy, and increasing maternal age are some factors that led to the increasing infertility issues that drive the high demand for fertility care and accelerate the industry growth. In 2021, Italy accounted for 21.70% of the industry share and was the leading country in Europe. The significant industry growth contributing factors addressed in Italy are the significant development and higher acceptance of fertility care services.

Fertility Supplements Market Report Scope

Report Attributes

Details

Market Size (2027)

USD 2.83 Billion

Market Size (2021)

USD 1.82 Billion

CAGR (2021-2027)

8 %

Base Year

2021

Forecast Year

2022-2027

Market Segments

Form, Type, Gender, Purchase Channels, and Geography

Geographic Analysis

North America, Europe, APAC, Latin America, and Middle East & Africa

Key Leading Countries

The US, Canada, Germany, Italy, Spain, France, the UK, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa, and the UAE

Key Prominent Vendors

Coast Science, Exeltis USA, Fairhaven Health, LENUS Pharma GesmbH, Vitabiotics Ltd., AdvaCare Pharma, Bayer Ag, Beli, CaDi- Cambridge Diagnostic Imaging, Carlson Labs, DCMG Laboratories, Elan Healthcare, Eu Natural, Fermenta Biotech, FullWell, Hera (HeraNow), iNova Pharmaceuticals (Pty) Ltd., Laboratorios Fertypharm S.L., Life Extension, Nestlé, Nature's Craft, Nutra Business, Nua Fertility, Ocean Healthcare, Orthomol, Ovaterra, Pragati Biocare Pvt. Ltd., Premama, Puritan's Pride, Ritual, Renova Nutrition, Supplemena, Seeking Health, TTK, Thorne, Wellbeing Nutrition, and Zenith Nutrition

Page Number

295

Customization Request

If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3631

Click Here to Download the Free Sample Report

Rising Focus on Natural Fertility Supplements

Natural vitamin E-based fertility products are vital in boosting fertility and are natural antioxidants. It helps the fertilized egg stay attached to the uterine wall. Moreover, Ashwagandha herbs, Vitex, and adaptogens can boost fertility. Maca is a commonly used fertility aid solution. It contains a high level of p-methoxybenzyl isothiocyanate.

In some cases, it helps to increase sperm count concentration. Royal jelly is also a natural fertility supplement that increases testosterone. Olive oil and salmon solutions are natural sources of Coenzyme Q10 that are used to boost lagging fertility. It also helps with the energy production of mitochondria to process and recycle energy effectively. Due to proven results in users, the demand for natural fertility supplements is increasing. In addition, many companies are also involved in increasing their natural fertility supplements-based products.

New Product Launches

  • In 2022, the leading market player, Ovaterra, launched two prenatal vitamin supplement products, Advanced Prep 35-39 & Advanced Prenatal, designed for pre, during, and post-pregnancy care.
  • In 2022, Wellbeing Nutrition Indian, the fastest-growing plant-based nutrition company, will launch a SLOW nutraceutical product portfolio.
  • In 2022, the Natalist company launched new products such as fertility supplements for every stage of the reproductive journey. The company launched consumer fertility, pregnancy, and essential postpartum products around 100% plastic neutral, including CoQ10 gummies, prenatal gummies, and other fertility and pregnancy test products.
  • Nua fertility is one of the world-class fertility brands focused on innovation and delivery of world-class fertility products. In 2020, the company launched the fertility supplement, NuaBiome, for women.

Click Here to Download the Free Sample Report

Key Vendors

  • Coast Science
  • Exeltis USA
  • Fairhaven Health
  • LENUS Pharma GesmbH
  • Vitabiotics Ltd.
  • AdvaCare Pharma
  • Bayer Ag
  • Beli
  • CaDi- Cambridge Diagnostic Imaging
  • Carlson Labs
  • DCMG Laboratories
  • Elan Healthcare
  • Eu Natural
  • Fermenta Biotech
  • FullWell
  • Hera (HeraNow)
  • iNova Pharmaceuticals (Pty) Ltd.
  • Laboratorios Fertypharm S.L.
  • Life Extension
  • Nestlé
  • Nature's Craft
  • Nutra Business
  • Nua Fertility
  • Ocean Healthcare
  • Orthomol
  • Ovaterra
  • Pragati Biocare Pvt. Ltd.
  • Premama
  • Puritan's Pride
  • Ritual
  • Renova Nutrition
  • Supplemena
  • Seeking Health
  • TTK
  • Thorne
  • Wellbeing Nutrition
  • Zenith Nutrition

Market Segmentation

Form

  • Natural
  • Synthetic & Blend

Type

  • Capsule
  • Tablet
  • Soft Gel
  • Powder
  • Liquid

Gender

  • Women
  • Men

Purchase Channels

  • Over-the-counter (OTC)
  • Prescription

Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • APAC
    • Japan
    • China
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • UAE

Check Out Some of the Top-Selling Related Research Reports:

U.S. Assisted Reproductive Technology Market - The U.S. assisted reproductive technology market is expected to cross $4 billion by 2027. Key players with huge infrastructure and R&D support are expanding their footprint in the industry by implementing various marketing strategies to gain traction among end-users and increase their market presence.

U.S. Fertility Test Market - U.S. fertility test market is projected to reach USD 201.4 million in 2027. A fertility test is a procedure by which the fertility of males or females can assess, and search the fertile window during a month. Fertility tests are assessed by ovulation test kits, fertility monitors, and sperm testing. The increasing infertility prevalence and rising maternal age directly impact male and female fertility, driving the demand for fertility tests. The U.S. fertility test market is likely to develop due to favorable demographic and social/cultural shifts due to attractive long-term growth.

Fertility Test Market - The global fertility test market is expected to reach USD 659.71 million by 2027. The global fertility treatment is presumably to grow healthy due to attractive long-term growth from favorable demographic and social/cultural shifts. Fertility testing is a niche industry with high margins for manufacturers, especially for vendors offering kits, which males and females widely use.

U.S. In-Vitro Fertilization (IVF) Market- The U.S. in-vitro fertilization market is expected to reach USD 231.68 million by 2026. The presence of global, regional, and local vendors characterizes the US in-vitro fertilization market. In recent years, the global infertility treatment market has witnessed many strategic initiatives by key vendors, which is expected to intensify market competitiveness in the upcoming years. Infertility treatment is a niche industry with high margins for manufacturers, especially for vendors offering equipment, media, and related consumables, that are widely used during ART procedures.

Table of Content

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY FORM

4.3.2 MARKET SEGMENTATION BY TYPE

4.3.3 MARKET SEGMENTATION BY GENDER

4.3.4 MARKET SEGMENTATION BY PURCHASE CHANNEL

4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 PREMIUM INSIGHTS

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 ADVANCES, RESEARCH, & CREDIBILITY IN FERTILITY SUPPLEMENTS

9.2 INCREASE IN PRODUCT LAUNCHES

9.3 FOCUS ON NATURAL FERTILITY SUPPLEMENTS

10 MARKET GROWTH ENABLERS

10.1 INCREASE IN PREVALENCE OF INFERTILITY RATE

10.2 INCREASE IN GOVERNMENT & PUBLIC INITIATIVES FOR FERTILITY AWARENESS

10.3 TREND OF DELAYED PREGNANCIES

11 MARKET RESTRAINTS

11.1 LACK OF AWARENESS & LOW ACCESS TO FERTILITY TREATMENTS IN EMERGING MARKETS

11.2 SIDE EFFECTS RELATED TO FERTILITY SUPPLEMENTS

11.3 PRESENCE OF ALTERNATIVES TO FERTILITY SUPPLEMENTS

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.1.1 INSIGHT BY GEOGRAPHY

12.1.2 INSIGHT BY PURCHASE CHANNEL

12.1.3 INSIGHT BY FORM

12.1.4 INSIGHT BY TYPE

12.1.5 INSIGHTS BY GENDER

12.2 MARKET SIZE & FORECAST

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 FORM

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 NATURAL

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 SYNTHETIC & BLEND

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

14 TYPE

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 CAPSULE

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 TABLET

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 SOFT GEL

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

14.6 POWDER

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 MARKET BY GEOGRAPHY

14.7 LIQUID

14.7.1 MARKET OVERVIEW

14.7.2 MARKET SIZE & FORECAST

14.7.3 MARKET BY GEOGRAPHY

15 GENDER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 WOMEN

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 MEN

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

16 PURCHASE CHANNEL

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 OVER-THE-COUNTER (OTC)

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 PRESCRIPTION

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 FORM

18.3.1 MARKET SIZE & FORECAST

18.4 TYPE

18.4.1 MARKET SIZE & FORECAST

18.5 GENDER

18.5.1 MARKET SIZE & FORECAST

18.6 PURCHASE CHANNEL

18.6.1 MARKET SIZE & FORECAST

18.7 KEY COUNTRIES

18.7.1 ITALY: MARKET SIZE & FORECAST

18.7.2 SPAIN: MARKET SIZE & FORECAST

18.7.3 GERMANY: MARKET SIZE & FORECAST

18.7.4 UK: MARKET SIZE & FORECAST

18.7.5 FRANCE: MARKET SIZE & FORECAST

19 NORTH AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 FORM

19.3.1 MARKET SIZE & FORECAST

19.4 TYPE

19.4.1 MARKET SIZE & FORECAST

19.5 GENDER

19.5.1 MARKET SIZE & FORECAST

19.6 PURCHASE CHANNEL

19.6.1 MARKET SIZE & FORECAST

19.7 KEY COUNTRIES

19.7.1 US: MARKET SIZE & FORECAST

19.7.2 CANADA: MARKET SIZE & FORECAST

20 APAC

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 FORM

20.3.1 MARKET SIZE & FORECAST

20.4 TYPE

20.4.1 MARKET SIZE & FORECAST

20.5 GENDER

20.5.1 MARKET SIZE & FORECAST

20.6 PURCHASE CHANNEL

20.6.1 MARKET SIZE & FORECAST

20.7 KEY COUNTRIES

20.7.1 JAPAN: MARKET SIZE & FORECAST

20.7.2 CHINA: MARKET SIZE & FORECAST

20.7.3 INDIA: MARKET SIZE & FORECAST

20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 FORM

21.3.1 MARKET SIZE & FORECAST

21.4 TYPE

21.4.1 MARKET SIZE & FORECAST

21.5 GENDER

21.5.1 MARKET SIZE & FORECAST

21.6 PURCHASE CHANNEL

21.6.1 MARKET SIZE & FORECAST

21.7 KEY COUNTRIES

21.7.1 BRAZIL: MARKET SIZE & FORECAST

21.7.2 MEXICO: MARKET SIZE & FORECAST

21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.3 FORM

22.3.1 MARKET SIZE & FORECAST

22.4 TYPE

22.4.1 MARKET SIZE & FORECAST

22.5 GENDER

22.5.1 MARKET SIZE & FORECAST

22.6 PURCHASE CHANNEL

22.6.1 MARKET SIZE & FORECAST

22.7 KEY COUNTRIES

22.7.1 TURKEY: MARKET SIZE & FORECAST

22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

22.7.4 UAE: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.2 MARKET SHARE ANALYSIS

23.2.1 COAST SCIENCE

23.2.2 EXELTIS USA

23.2.3 FAIRHAVEN HEALTH

23.2.4 LENUS PHARMA GESMBH

23.2.5 VITABIOTICS

24 KEY COMPANY PROFILES

24.1 COAST SCIENCE

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.1.3 KEY STRATEGIES

24.1.4 KEY STRENGTHS

24.1.5 KEY OPPORTUNITIES

24.2 EXELTIS USA

24.3 FAIRHAVEN HEALTH

24.4 LENUS PHARMA GESMBH

24.5 VITABIOTICS

25 OTHER PROMINENT VENDORS

25.1 ADVACARE PHARMA

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT OFFERINGS

25.2 BAYER AG

25.3 BELI

25.4 CADI - CAMBRIDGE DIAGNOSTIC IMAGING

25.5 CARLSON LABS

25.6 DCMG LABORATORIES

25.7 ELAN HEALTHCARE

25.8 EU NATURAL

25.9 FERMENTA BIOTECH

25.10 FULLWELL

25.11 HERA (HERANOW)

25.12 INOVA PHARMACEUTICALS (PTY) LTD.

25.13 LABORATORIOS FERTYPHARM S.L.

25.14 LIFE EXTENSION

25.15 NESTLÉ

25.16 NATURE'S CRAFT

25.17 NUTRA BUSINESS

25.18 NUA FERTILITY

25.19 OCEAN HEALTHCARE

25.20 ORTHOMOL

25.21 OVATERRA

25.22 PRAGATI BIOCARE PVT. LTD.

25.23 PREMAMA

25.24 PURITAN'S PRIDE

25.25 RITUAL

25.26 RENOVA NUTRITION

25.27 SUPPLEMENA

25.28 SEEKING HEALTH

25.29 TTK

25.30 THORNE

25.31 WELLBEING NUTRITION

25.32 ZENITH NUTRITION

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY GEOGRAPHY

27.2 MARKET BY FORM

27.3 MARKET BY TYPE

27.4 MARKET BY GENDER

27.5 MARKET BY PURCHASE CHANNEL

27.6 FORM: MARKET BY GEOGRAPHY

27.6.1 NATURAL: MARKET BY GEOGRAPHY

27.6.2 SYNTHETIC & BLEND: MARKET BY GEOGRAPHY

27.7 TYPE: MARKET BY GEOGRAPHY

27.7.1 CAPSULE: MARKET BY GEOGRAPHY

27.7.2 TABLET: MARKET BY GEOGRAPHY

27.7.3 SOFT GEL: MARKET BY GEOGRAPHY

27.7.4 POWDER: MARKET BY GEOGRAPHY

27.7.5 LIQUID: MARKET BY GEOGRAPHY

27.8 GENDER: MARKET BY GEOGRAPHY

27.8.1 WOMEN: MARKET BY GEOGRAPHY

27.8.2 MEN: MARKET BY GEOGRAPHY

27.9 PURCHASE CHANNEL: MARKET BY GEOGRAPHY

27.9.1 OTC: MARKET BY GEOGRAPHY

27.9.2 PRESCRIPTION: MARKET BY GEOGRAPHY

28 APPENDIX

28.1 ABBREVIATIONS

About Us:?

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.?

Click Here to Contact Us?

Call: +1-312-235-2040?

????????? +1 302 469 0707?

Mail: enquiry@arizton.com

Arizton Logo

Photo: https://mma.prnewswire.com/media/1980614/Fertility_Supplements_Market.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/the-demand-for-natural-fertility-supplements-is-boosting-the-global-fertility-supplement-market-the-demand-for-fertility-supplements-to-reach-almost-usd-3-billion-a-2x-growth-by-2027---arizton-301717998.html

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2023 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.